Skip to main content
. 2017 Mar 27;12(3):e0173979. doi: 10.1371/journal.pone.0173979

Fig 7. Both RV infection and therapeutic oral administration of BBG9-1 affect the gut microbiota of mice.

Fig 7

Oral administration of BBG9-1 and inoculation of RV were performed as described in the legend of Fig 2. Contents of the small intestine and contents of the cecum and colon were harvested 2 days after infection and subjected to microbiota analysis. Bacterial relative abundances in (A) the small intestine and (B) the cecum and colon were measured. Data are shown as means (n = 5–8 pups for each group). Bifidobacterium relative abundances in (C) the small intestine and (D) the cecum and colon were measured. Data are shown as means ± S.E (n = 5–8 pups for each group) **p < 0.01 compared with the Non-RV group; #p<0.05 compared with the RV-Control group by the Tukey-Kramer test.